British American Tobacco issues statement in response to U.S. International Trade Commission said that Philip Morris and Altria’s IQOS products infringe two of its patents.
- BAT “is investing significantly behind its unique multi-category portfolio of scientifically-substantiated potentially reduced risk nicotine products”
- “Infringement of our intellectual property undermines our ability to invest and innovate and thereby reduce the health impact of our business. We will therefore defend our IP robustly across the globe.”
- NOTE:
Philip Morris IQOS Imports Barred in Reynolds Tobacco Fight
To view the source of this information, click
To contact the reporter on this story:
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.